William Blair & Company’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49M Buy
292,513
+444
+0.2% +$10.5K 0.02% 430
2026
Q1
$4.37M Hold
292,069
0.01% 533
2025
Q4
$4.25M Buy
292,069
+336
+0.1% +$5.86K 0.01% 563
2025
Q3
$5.23M Sell
291,733
-13,195
-4% -$194K 0.01% 505
2025
Q2
$5.21M Buy
304,928
+24,053
+9% +$241K 0.01% 484
2025
Q1
$2.03M Sell
280,875
-101,035
-26% -$1.15M 0.01% 708
2024
Q4
$5.37M Sell
381,910
-588,357
-61% -$8.69M 0.02% 479
2024
Q3
$11.5M Buy
970,267
+451,254
+87% +$4.68M 0.03% 323
2024
Q2
$4.83M Buy
519,013
+192,580
+59% +$984K 0.01% 500
2024
Q1
$1.16M Buy
+326,433
New +$1.13M ﹤0.01% 822

Other funds holding CORZ

William Blair & Company's CORZ Position: Q2 2026 in Review

William Blair & Company increased its Core Scientific (CORZ) stake by 0.15% in Q2 2026, buying an estimated $10.5K and bringing the position to 292,513 shares worth $7.49M. The position accounts for 0.02% of the portfolio, ranked #430.

William Blair & Company first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.5M in Q3 2024. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • William Blair & Company held 292,513 shares of Core Scientific worth $7.49M as of Q2 2026.
  • William Blair & Company bought 444 Core Scientific shares in Q2 2026, an estimated $10.5K.
  • Core Scientific made up 0.02% of William Blair & Company's portfolio in Q2 2026, its #430 holding.
  • William Blair & Company first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • William Blair & Company's Core Scientific position peaked at $11.5M in Q3 2024.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.